Ryvu Therapeutics S.A. (WSE:RVU)

Ryvu Therapeutics Revenue

Ryvu Therapeutics had revenue of 95.03M PLN in the quarter ending June 30, 2025, with 17.44% growth. This brings the company's revenue in the last twelve months to 130.10M, down -32.25% year-over-year. In the year 2024, Ryvu Therapeutics had annual revenue of 101.96M with 51.51% growth.

• Revenue (ttm): 130.10M
• Revenue Growth: -32.25%
• P/S Ratio: 3.51
• Revenue / Employee: 396.63K
• Employees: 328
• Market Cap: 457.05M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	101.96M	34.67M	51.51%
Dec 31, 2023	67.30M	-1.14M	-1.67%
Dec 31, 2022	68.44M	33.02M	93.25%
Dec 31, 2021	35.41M	-1.54M	-4.16%
Dec 31, 2020	36.95M	3.23M	9.58%